Changing paradigms in dermatology: tumor necrosis factor alpha (tnf- ) blockade in psoriasis and psoriatic arthritis

By Victor F.C.   Gottlieb A.B.   Menter A.  

Clinics in Dermatology, Vol. 21, Iss. 5, 2003-09 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

A retrospective analysis of combination methotrexate–cyclosporine therapy in moderate–severe psoriasis

By Mohanan Saritha   Ramassamy Sivaranjini   Chandrashekar Laxmisha   Thappa Devinder Mohan  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 50-53

Informa Healthcare

Access to resources Recommend Favorite

Intralesional therapy for psoriasis

By Wang Ting-Shun   Tsai Tsen-Fang  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 340-347

Informa Healthcare

Access to resources Recommend Favorite

Exacerbation of Psoriasis after Treatment with an EGFR Tyrosine Kinase Inhibitor

By Zorzou Markella-Pagona   Stratigos Alexandros   Efstathiou Eleni   Bamias Aristotle  

Acta Dermato-Venereologica, Vol. 84, Iss. 4, 2004-07 ,pp. : 308-309

Medical Journals Limited

Access to resources Recommend Favorite

Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature

By Mahil SATVEER K.  

Journal of Dermatological Treatment, Vol. 24, Iss. 1, 2013-02 ,pp. : 38-49

Informa Healthcare

Access to resources Recommend Favorite